Brief: Bluebird Intends To Restate Financial Statements As Of And For Year Ended Dec 31, 2022 In Connection With Filing Of 2023 Form 10-K

bluebird bio

26/03/2024 11:15

March 26 (Reuters) - bluebird bio Inc  BLUE.O :
    * BLUEBIRD BIO -INTENDS TO RESTATE CONSOLIDATED FINANCIAL
STATEMENTS AS OF AND FOR YEAR ENDED DEC 31, 2022 IN CONNECTION
WITH FILING OF 2023 FORM 10-K
    * BLUEBIRD BIO INC - AT THIS TIME, EXPECTS TO FILE 2023 FORM
10-K
NO LATER THAN APRIL 16, 2024
    * BLUEBIRD BIO - EXPECTS TO CONTINUE TO REPORT THAT THERE IS
SUBSTANTIAL DOUBT REGARDING ITS ABILITY TO CONTINUE AS A GOING
CONCERN

Source text for Eikon:  ID:n0001293971-24-000010 
Further company coverage:  BLUE.O 

 ((Reuters.Briefs@thomsonreuters.com;))